Multiple-Ascending-Dose Phase 1 Clinical Study of the Safety, Tolerability, and Pharmacokinetics of CRS3123, a Narrow-Spectrum Agent with Minimal Disruption of Normal Gut Microbiot... von Lomeli, Barbara K, Galbraith, Hal, Schettler, Jared, Saviolakis, George A, El-Amin, Wael, Osborn, Blaire, Ravel, Jacques, Hazleton, Keith, Lozupone, Catherine A, Evans, Ronald J, Bell, Stacie J, Ochsner, Urs A, Jarvis, Thale C, Baqar, Shahida, Janjic, Nebojsa

Volltext